The US Food and Drug Administration on Wednesday said it will allow the use of new qualified health claims stating that consuming eicosapentaenoic acid (EPA) and docosahexaenoic (DHA) omega-3 fatty acids in food or dietary supplements may reduce the risk of hypertension and coronary heart disease.
The FDA determined that while the overall evidence of omega-3s benefits on health did not meet the “significant scientific agreement” standard required for an authorized health claim, it did meet the “credible evidence” standard for a qualified health claim in the labeling of conventional foods and dietary supplements…
Recent Comments